Care for head and neck cancer increasingly regionalized

Care for head and neck cancer increasingly regionalized
Care for head and neck cancer is becoming increasingly regionalized, according to research published online Sept. 5 in JAMA Otolaryngology-Head & Neck Surgery.

(HealthDay)—Care for head and neck cancer is becoming increasingly regionalized, according to research published online Sept. 5 in JAMA Otolaryngology-Head & Neck Surgery.

Neil Bhattacharyya, M.D., of Harvard Medical School in Boston, and Elliot Abemayor, M.D., Ph.D., of the David Geffen School of Medicine at the University of California in Los Angeles, analyzed data for 2000, 2005, and 2010 from a national health care database to assess regionalization of head and neck cancer care.

The researchers observed an increase in the percentage of admissions for to teaching hospitals, from 61.7 percent in 2000 to 64.2 percent in 2005 and 79.8 percent in 2010. A similar pattern was seen in the percentage of cases in large hospitals according to bed size, with increases from 69.2 to 71.4 and 73.3 percent, respectively. No significant change in the distribution of primary payers, including Medicare (39.6 percent), private insurance (33.3 percent), and Medicaid (17.4 percent), was observed for the calendar years examined in the study.

"Head and neck oncologic care is increasingly being regionalized to teaching hospitals and academic centers," the authors write. "A better understanding of how care is distributed will improve our understanding of the financial and educational impact of compacting treatment of these patients."

More information: Abstract
Full Text (subscription or payment may be required)

add to favorites email to friend print save as pdf

Related Stories

Racial disparity in head and neck cancer outcomes

Apr 19, 2013

(HealthDay)—Among Medicaid beneficiaries diagnosed with head and neck cancer, considerable racial disparities exist in treatment patterns and survival, according to a study published online April 18 in ...

Recommended for you

Bone loss drugs may help prevent endometrial cancer

10 hours ago

A new analysis suggests that women who use bisphosphonates—medications commonly used to treat osteoporosis and other bone conditions—have about half the risk of developing endometrial cancer as women who do not use the ...

User comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.